Introduction
The ability to edit eukaryotic DNA entails an almost limitless ability to alter the genetic makeup of the plants that become our food. Recently, scientific attention has been directed to applying a class of new gene-editing techniques that utilize CRISPR to food crops for the introduction of commercially desirable traits. Gene-edited crops can have a positive impact on food productivity, quality, and environmental sustainability, and CRISPR is unique in its relative simplicity, robust flexibility, cost-effectiveness, and wide scope of use. The increased use of CRISPR in agriculture has endless applications, the consequences of which are only recently being analyzed.
CRISPR & the Power of Gene Editing
The term CRISPR refers generally to a class of gene-editing mechanisms derived from prokaryotic immune systems. These mechanisms feature two main components: guiding RNA molecules that direct the second component, CRISPR-associated ("Cas") proteins, to the target region of cellular DNA. These Cas proteins induce a double-stranded break in the DNA and allow for targeted manipulation of the desired genetic code. There is incredible diversity in the CRISPR-Cas system and a multitude of different Cas proteins that can be fine-tuned to induce desired changes with high specificityincluding the activation or deactivation of individual genes, or the insertion of genes from other organisms into the target genome.
CRISPR's flexibility stands in sharp contrast to the previous generation of gene-editing technologies, such as Zinc Finger Nucleases and Transcription Activator-Like Effector Nucleases ("TALENs"), which require massive amounts of preemptive research and development and have a far more limited scope of use. This simultaneous precision and flexibility therefore provides ample opportunity for gene-edited optimization of food crops and has already been used in some instances to create, for example, browning-resistant mushrooms. In late 2021, in Japan, the first CRISPR-edited food product was introduced to the global market: tomatoes with high levels of GABA, a naturally occurring neurotransmitter, due to a CRISPR-inactivated gene.
The power of CRISPR has incredible potential for innovation, but the rights and regulations associated with CRISPR have been elusive and, at times, contentious. CRISPR's game-changing technology was the subject of a series of patent priority, inventorship, and, hence, ownership disputes between high-profile research institutionsthe recent results of which have significant implications for global food supplies.
Patent Landscape
Like most cutting-edge technologies, the invention of CRISPR was accompanied by a flurry of patent application filings in the United States and elsewhere, as researchers who brought CRISPR to light sought to protect and monetize their rights as inventors. Numerous academic institutionsincluding Harvard's and MIT's Broad Institute, the University of California, University of Vienna, Vilnius University, The Rockefeller University, and companies such as ToolGen, Inc., Sigma-Aldrich (Millipore Sigma), Caribou Biosciences, Inc., Editas Medicine, Inc., Keygene N.V., Depixus, Blueallele Corp., and CRISPR Therapeutics AG, among numerous other institutions and companieshave secured U.S. and foreign patent rights related to the applications of CRISPR technology. As CRISPR continues to expand in use, especially in the case of CRISPR-edited agriculture that evade many regulations other GMO foods cannot, the complexity of the patent landscape will almost certainly continue to grow.
EU Regulatory Landscape
In general, the EU subjects agricultural products edited with CRISPR technology to the full suite of genetically modified organism ("GMO") premarket approval, safety, and labeling requirements. The primary EU regulation on point, Directive 2001/18/EC (the "GMO Directive"), was promulgated in 2001 by the European Parliament and Council of the European Union. The GMO Directive requires all EU Member States to create appropriate precautionary measures regarding the release of GMOs in the market. However, the definition of GMO in the GMO Directive apparently excludes CRISPR modification, stating that a GMO is as "an organism, with the exception of human beings, in which the genetic material has been altered in a way that does not occur naturally by mating and/or natural recombination."
It was not until 2018 that the EU addressed this gap in the GMO Directive. In July 2018, the Court of Justice of the European Union explained in Case C-528/16 that organisms obtained by mutagenesis are GMOs within the meaning of the GMO Directive. "Only organisms obtained by means of techniques/methods of mutagenesis which have conventionally been used in a number of applications and have a long safety record are excluded from the scope of that directive."
The following year, in November 2019, the Council of the EU formally requested that the European Commission "submit a study in light of the Court of Justice's judgment in Case C-528/16 regarding the status of novel genomic techniques under Union law, and a proposal, if appropriate in view of the outcomes of the study." The 117-page study was issued in April 2021, and ultimately affirms the holding in Case C-528/16, stating that the "study makes it clear that organisms obtained through new genomic techniques [including CRISPR] are subject to the GMO legislation." Based on the study's findings, the European Commission requested public input on proposed legislation for "plants obtained by targeted mutagenesis and cisgenesis and for their food and feed products." The public consultation period expired on July 22, 2022. The European Commission plans to finalize the proposed framework in 2023.
United States Regulatory Landscape
In contrast to the EU approach, the United States does not currently regulate CRISPR-edited agricultural products as GMOs. The United States regulates biotechnology and genetic modification in food through a "Coordinated Framework" between the U.S. Department of Agriculture ("USDA"), Food and Drug Administration ("FDA"), and Environmental Protection Agency ("EPA").
At a high level, the USDA regulates the use of biotechnology in plant products through the Plant Protection Act. The USDA explains that the Plant Protection Act provides the USDA's Animal and Plant Health Inspection Service ("APHIS") with authority to regulate "organisms and products that are known or suspected to be plant pests or to pose a plant pest risk, including those that have been altered or produced through genetic engineering." Further, in 2018, the USDA's Agricultural Marketing Service promulgated the National Bioengineered Food Disclosure Standard, 7 CFR Part 66 (the "BE Disclosure Standard"), which created a "new national mandatory bioengineered [] food disclosure standard" and associated recordkeeping requirements, effective January 1, 2022. The BE Disclosure Standard defines bioengineered food as food products that contain "genetic material that has been modified through in vitro [DNA]" and "for which the modification could not otherwise be obtained through conventional breeding or found in nature." Notably, the USDA has not explicitly clarified whether CRISPR-edited agricultural products are considered "bioengineered foods" and subject to the BE Disclosure Standard. Rather, in a presentation from 2020, the USDA stated that it "intends to make determinations about whether a specific modifications would be considered 'found in nature' or obtained through 'conventional breeding' on a case-by-case basis." (For more information on the BE Disclosure Standard, refer to Jones Day's May 2022 publication, Are Your Labels Up to Date? Assuring Compliance with the USDA's National Bioengineered Food Disclosure Standard.)
Additionally, the FDA regulates the use of biotechnology in plants with a focus on ensuring that foods are safe for human consumption. In 1992, the FDA issued a Statement of Policy regarding Foods Derived from New Plant Varieties, in which the FDA stated that "[t]he regulatory status of a food, irrespective of the method by which it is developed, is dependent upon objective characteristics of the food and the intended use of the food (or its components)." Since then, the FDA has reviewed genetic modifications to food in the context of food additives, such that FDA approval is required to use food additives unless it is generally recognized as safe ("GRAS"). In the opinion of the FDA, a GMO is not GRAS if the altered substance "differs significantly in structure, function or composition from substances found currently in food." In contrast, a GMO is GRAS if it is "naturally occurring" in the food product, even if is bioengineered to be present at a "greater level" than found in nature or if there are "minor variations in molecular structure that do not affect safety." As explained in the introduction, CRISPR technology differs from conventional gene editing because it does not introduce new substances into a product that are not naturally present. Accordingly, CRISPR-edited agricultural products are not generally regulated by the FDA as food additives.
The EPA also reviews the use of biotechnology in plants, as it regulates the distribution, sale, and use of pesticides to ensure that they will "not pose unreasonable risks to human health or the environment when used according to label directions." Further, when the EPA evaluates plant-incorporated protectants ("PIPs"), which are genetically engineered pesticides, the EPA "requires extensive studies containing numerous factors, such as risks to human health, nontarget organisms, and the environment; potential for gene flow; and the need for insect resistance management plans." As such, CRISPR-edited pesticides may be regulated by the EPA as PIPs.
Conclusion
The patent and regulatory landscapes of the use of CRISPR technology in food are continuing to unfold across the world. Accordingly, agriculture companies and the broader agricultural industry should pay close attention to all developments.
Read the rest here:
CRISPR Technology in the Agricultural Industry: Patent and Regulatory Updates - JD Supra
- Genetic Engineering (excerpt) - Video [Last Updated On: January 9th, 2012] [Originally Added On: January 9th, 2012]
- Promising early results with therapeutic cancer vaccines [Last Updated On: February 16th, 2012] [Originally Added On: February 16th, 2012]
- Genetic Risk and Stressful Early Infancy Join to Increase Risk for Schizophrenia [Last Updated On: March 27th, 2012] [Originally Added On: March 27th, 2012]
- Innovative cell printing technologies hold promise for tissue engineering R&D [Last Updated On: March 28th, 2012] [Originally Added On: March 28th, 2012]
- SAGE® Labs Creates The First Tissue-Specific Gene Deletion In Rats [Last Updated On: April 21st, 2012] [Originally Added On: April 21st, 2012]
- Devangshu Datta: Towards an HIV cure [Last Updated On: May 5th, 2012] [Originally Added On: May 5th, 2012]
- Now *This* Is a Cell Phone: Using Radio Waves to Control Specific Genes in Mice | 80beats [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- Genetic packing: Successful stem cell differentiation requires DNA compaction, study finds [Last Updated On: May 11th, 2012] [Originally Added On: May 11th, 2012]
- Premier issue of BioResearch Open Access launched by Mary Ann Liebert Inc. publishers [Last Updated On: May 17th, 2012] [Originally Added On: May 17th, 2012]
- GEN reports on growth of tissue engineering revenues [Last Updated On: July 11th, 2012] [Originally Added On: July 11th, 2012]
- New therapeutic target for prostate cancer identified [Last Updated On: July 18th, 2012] [Originally Added On: July 18th, 2012]
- Novel pig model may be useful for human cancer studies [Last Updated On: July 24th, 2012] [Originally Added On: July 24th, 2012]
- New gene therapy strategy boosts levels of deficient protein in Friedreich's ataxia [Last Updated On: July 25th, 2012] [Originally Added On: July 25th, 2012]
- Should high-dose interleukin-2 continue to be the treatment of choice for metastatic melanoma? [Last Updated On: July 26th, 2012] [Originally Added On: July 26th, 2012]
- New marker for identifying precursors to insulin-producing cells in pancreas [Last Updated On: August 22nd, 2012] [Originally Added On: August 22nd, 2012]
- 3D Biomatrix’s Perfecta3D® Hanging Drop Plates Featured in Prominent Life Science Journals [Last Updated On: October 1st, 2012] [Originally Added On: October 1st, 2012]
- Progress in Cell-SELEX compound screening technology reviewed in BioResearch Open Access [Last Updated On: October 18th, 2012] [Originally Added On: October 18th, 2012]
- Can the addition of radiolabeled treatments improve outcomes in advanced metastatic disease? [Last Updated On: November 14th, 2012] [Originally Added On: November 14th, 2012]
- Is the detection of early markers of Epstein Barr virus of diagnostic value? [Last Updated On: November 18th, 2012] [Originally Added On: November 18th, 2012]
- Genetic Engineering Of Mesenchymal Stem Cells - Video [Last Updated On: November 18th, 2012] [Originally Added On: November 18th, 2012]
- Ramble: Simelweis Taboo - Video [Last Updated On: December 12th, 2012] [Originally Added On: December 12th, 2012]
- The Super Protein That Can Cut DNA and Revolutionize Genetic Engineering [Last Updated On: March 22nd, 2013] [Originally Added On: March 22nd, 2013]
- Cellular Dynamics International Expands MyCell Products Line with Disease Models, Genetic Engineering Patents [Last Updated On: June 5th, 2013] [Originally Added On: June 5th, 2013]
- World Stem Cell Summit to be presented by Genetics Policy Institute, Mary Ann Liebert, Inc., and Genetic Engineering ... [Last Updated On: June 11th, 2013] [Originally Added On: June 11th, 2013]
- Genetic engineering - Wikipedia, the free encyclopedia [Last Updated On: November 1st, 2013] [Originally Added On: November 1st, 2013]
- Genetic Engineering: What is Genetic Engineering? [Last Updated On: November 1st, 2013] [Originally Added On: November 1st, 2013]
- Critical factor (BRG1) identified for maintaining stem cell pluripotency [Last Updated On: February 7th, 2014] [Originally Added On: February 7th, 2014]
- Genome Surgery [Last Updated On: February 11th, 2014] [Originally Added On: February 11th, 2014]
- Engineering The Human Genome One Letter At A Time [Last Updated On: February 11th, 2014] [Originally Added On: February 11th, 2014]
- CRISPR is the technology that could allow researchers to perform microsurgery on genes [Last Updated On: February 15th, 2014] [Originally Added On: February 15th, 2014]
- Joseph Glorioso, Ph.D., receives Pioneer Award [Last Updated On: February 19th, 2014] [Originally Added On: February 19th, 2014]
- Commentary: field of tissue engineering is progressing at remarkable pace [Last Updated On: March 5th, 2014] [Originally Added On: March 5th, 2014]
- Pioneer Award recipients Marina Cavazzana and Adrian Thrasher recognized for advancing gene therapy to the clinic for ... [Last Updated On: March 24th, 2014] [Originally Added On: March 24th, 2014]
- New method yields potent, renewable human stem cells with promising therapeutic properties [Last Updated On: March 25th, 2014] [Originally Added On: March 25th, 2014]
- First evidence that very small embryonic-like stem cells [Last Updated On: April 2nd, 2014] [Originally Added On: April 2nd, 2014]
- Scarless wound healing -- applying lessons learned from fetal stem cells [Last Updated On: April 11th, 2014] [Originally Added On: April 11th, 2014]
- Novel marker discovered for stem cells derived from human umbilical cord blood [Last Updated On: April 18th, 2014] [Originally Added On: April 18th, 2014]
- GENs Top 10 Session Picks for the 2014 BIO International Convention [Last Updated On: May 2nd, 2014] [Originally Added On: May 2nd, 2014]
- A Vaccine for Heart Disease Could Mean No Pills, Lettuce or a Gym [Last Updated On: June 14th, 2014] [Originally Added On: June 14th, 2014]
- Gene editing tool can write HIV out of the picture [Last Updated On: June 22nd, 2014] [Originally Added On: June 22nd, 2014]
- Inner ear stem cells hold promise for restoring hearing [Last Updated On: June 24th, 2014] [Originally Added On: June 24th, 2014]
- New method to grow zebrafish embryonic stem cells can regenerate whole fish [Last Updated On: June 30th, 2014] [Originally Added On: June 30th, 2014]
- Novel methods may help stem cells survive transplantation into damaged tissues [Last Updated On: July 22nd, 2014] [Originally Added On: July 22nd, 2014]
- New method for reducing tumorigenicity in induced pluripotent stem-cell based therapies [Last Updated On: July 24th, 2014] [Originally Added On: July 24th, 2014]
- Malcolm K. Brenner receives Pioneer Award for advances in gene-modified T cells targeting cancer [Last Updated On: July 26th, 2014] [Originally Added On: July 26th, 2014]
- Conclusive evidence on role of circulating mesenchymal stem cells in organ injury [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- New genomic editing methods produce better disease models from patient-derived iPSCs [Last Updated On: September 8th, 2014] [Originally Added On: September 8th, 2014]
- Tory Williams combats controversy surrounding stem cell therapy with new book [Last Updated On: September 11th, 2014] [Originally Added On: September 11th, 2014]
- NYIT Expert Predicts Growth in Demand for 3D Kidneys, Livers and Hearts [Last Updated On: December 9th, 2014] [Originally Added On: December 9th, 2014]
- The 'Berlin patient,' first and only person cured of HIV, speaks out [Last Updated On: January 6th, 2015] [Originally Added On: January 6th, 2015]
- Integrins are essential in stem cell binding to defective cartilage for joint regeneration [Last Updated On: January 27th, 2015] [Originally Added On: January 27th, 2015]
- Scientists urge caution in using new CRISPR technology to treat human genetic disease [Last Updated On: March 20th, 2015] [Originally Added On: March 20th, 2015]
- Scientists call for caution in using DNA-editing technology [Last Updated On: March 23rd, 2015] [Originally Added On: March 23rd, 2015]
- 'Ban DNA Editing Of Sperm And Eggs' [Last Updated On: March 23rd, 2015] [Originally Added On: March 23rd, 2015]
- Mount Sinai Researchers Discover Genetic Origins of Myelodysplastic Syndrome Using Stem Cells [Last Updated On: March 26th, 2015] [Originally Added On: March 26th, 2015]
- Researchers discover genetic origins of myelodysplastic syndrome using stem cells [Last Updated On: March 26th, 2015] [Originally Added On: March 26th, 2015]
- Pulling the strings of our genetic puppetmasters [Last Updated On: April 6th, 2015] [Originally Added On: April 6th, 2015]
- Going deep on life extension investments and human genetic engineering (Morning Read) [Last Updated On: April 6th, 2015] [Originally Added On: April 6th, 2015]
- Genetic engineering: a guide for kids by Tiki the Penguin [Last Updated On: July 8th, 2015] [Originally Added On: July 8th, 2015]
- genetic engineering | Britannica.com [Last Updated On: July 20th, 2015] [Originally Added On: July 20th, 2015]
- Interactives . DNA . Genetic Engineering [Last Updated On: August 3rd, 2015] [Originally Added On: August 3rd, 2015]
- Genetic engineering - Memory Alpha, the Star Trek Wiki [Last Updated On: September 10th, 2015] [Originally Added On: September 10th, 2015]
- Genetic Engineering Careers in India : How to become a ... [Last Updated On: September 10th, 2015] [Originally Added On: September 10th, 2015]
- Genetic Engineering (song) - Wikipedia, the free encyclopedia [Last Updated On: August 8th, 2016] [Originally Added On: August 8th, 2016]
- Genetic Engineering - BiologyMad [Last Updated On: September 28th, 2016] [Originally Added On: September 28th, 2016]
- UNL's AgBiosafety for Educators [Last Updated On: September 28th, 2016] [Originally Added On: September 28th, 2016]
- Recent Articles | Genetic Engineering | The Scientist ... [Last Updated On: October 20th, 2016] [Originally Added On: October 20th, 2016]
- Human Genetic Engineering - Popular Issues [Last Updated On: October 29th, 2016] [Originally Added On: October 29th, 2016]
- Explore More: Genetic Engineering - iptv.org [Last Updated On: October 29th, 2016] [Originally Added On: October 29th, 2016]
- Genetic Engineering and GM Crops - Pocket K | ISAAA.org [Last Updated On: November 10th, 2016] [Originally Added On: November 10th, 2016]
- Pros and Cons of Genetic Engineering | HRFnd [Last Updated On: November 10th, 2016] [Originally Added On: November 10th, 2016]
- Genetic Engineering - The New York Times [Last Updated On: November 10th, 2016] [Originally Added On: November 10th, 2016]
- Genetic Engineering | MSPCA-Angell [Last Updated On: November 10th, 2016] [Originally Added On: November 10th, 2016]
- What is genetic engineering? - Definition from WhatIs.com [Last Updated On: November 10th, 2016] [Originally Added On: November 10th, 2016]
- Genetic Engineering in Agriculture | Union of Concerned ... [Last Updated On: November 16th, 2016] [Originally Added On: November 16th, 2016]
- Free genetic engineering Essays and Papers - 123helpme [Last Updated On: November 20th, 2016] [Originally Added On: November 20th, 2016]
- Gene therapy - Wikipedia [Last Updated On: November 20th, 2016] [Originally Added On: November 20th, 2016]
- Writing the human genome - The Biological SCENE [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- America's First Free-Roaming Genetically Engineered Insects Are ... - Gizmodo [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Stanford's Final Exams Pose Question About the Ethics of Genetic Engineering - Futurism [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]